Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice

PURPOSE: Immune checkpoint inhibitors (ICI) have shown marked responses in patients with non-small cell lung cancer (NSCLC) in clinical trials. However, because such trials comprise cohorts selected based on specific criteria, it is unclear if their results represent routine clinical practice. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Beung-Chul, Pyo, Kyoung-Ho, Xin, Chun-Feng, Jung, Dongmin, Shim, Hyo Sup, Lee, Chang Young, Park, Seong Yong, Yoon, Hong In, Hong, Min Hee, Cho, Byoung Chul, Kim, Hye Ryun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527531/
https://www.ncbi.nlm.nih.gov/pubmed/30911841
http://dx.doi.org/10.1007/s00432-019-02899-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527531/
https://www.ncbi.nlm.nih.gov/pubmed/30911841
http://dx.doi.org/10.1007/s00432-019-02899-y

Ejemplares similares